Atlas Trials

A Single Dose Study to Investigate the Pharmacokinetics of MK-0941 in Participants With Renal Insufficiency (MK-0941-015-02)

Clinical trial NCT00830791 · TERMINATED

Trial details

NCT number
NCT00830791
Sponsor
Merck Sharp & Dohme LLC
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2009-01-01
Primary completion
2009-09-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.